Observation Study of T-Gel (1%) in Treatment of Adolescent Boys With Hypogonadism
NCT ID: NCT00193661
Last Updated: 2015-01-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
INTERVENTIONAL
2002-08-31
2007-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pharmacokinetic Evaluation of Testosterone Gel (1%)
NCT00193700
Efficacy, Pharmacokinetics and Safety of Testosterone
NCT01370369
A Clinical Trial to Evaluate the Efficacy and Safety of Testosterone Gel
NCT01665599
A Clinical Trial to Evaluate the Efficacy and Safety of Testosterone Gel in Adult Hypogonadal Males
NCT02149264
Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
NCT01403116
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
TREATMENT
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Testosterone Gel (1%)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Generalized skin disease
* Contraindication to testosterone or androgen products
13 Years
17 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Unimed Pharmaceuticals
INDUSTRY
Solvay Pharmaceuticals
INDUSTRY
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Global Clinical Director Solvay
Role: STUDY_DIRECTOR
Solvay Pharmaceuticals
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Site 130
Birmingham, Alabama, United States
Site 107
Los Angeles, California, United States
Site 113
Sacramento, California, United States
Site 114
Torrance, California, United States
Site 121
Gainesville, Florida, United States
Site 127
Jacksonville, Florida, United States
Site 128
Jacksonville, Florida, United States
Site 117
Indianapolis, Indiana, United States
Site 111
Kansas City, Missouri, United States
Site 129
Brooklyn, New York, United States
Site 123
New York, New York, United States
Site 131
Cincinnati, Ohio, United States
Site 124
Columbus, Ohio, United States
Site 103
Portland, Oregon, United States
Site 109
Hershey, Pennsylvania, United States
Site 125
Philadelphia, Pennsylvania, United States
Site 126
Philadelphia, Pennsylvania, United States
Site 104
Memphis, Tennessee, United States
Site 205
Seattle, Washington, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UMD-01-090
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.